SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-22-031052
Filing Date
2022-11-09
Accepted
2022-11-09 10:11:24
Documents
1
Period of Report
2022-10-28

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2896
  Complete submission text file 0001493152-22-031052.txt   4288
Mailing Address ONE RESEARCH COURT SUITE 450 ROCKVILLE MD 20850
Business Address ONE RESEARCH COURT SUITE 450 ROCKVILLE MD 20850 2404034212
Shuttle Pharmaceuticals Holdings, Inc. (Issuer) CIK: 0001757499 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address SHUTTLE PHARMACEUTICALS HOLDINGS, INC. 1 RESEARCH COURT, SUITE 450 ROCKVILLE MD 20850
Business Address
Jacobs Bette (Reporting) CIK: 0001953668 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41488 | Film No.: 221371052